Tom graduated University of Brighton with a BA (Hons) degree in Broadcast Journalism, leaving as the valedictorian of the class of 2015. His final year projects and dissertation were nominated for, and won, several awards, whilst he was also the Editor-in-Chief of the university’s news site during his time at Brighton. After previously writing for a property magazine, Tom joined the Proactive team in January 2016.
“That [Redx] has attracted such an award is testament to its innovation and research prowess in the development of novel antibiotics”
There is also the option to draw down another £2mln in the next couple of months, which could take the total amount up to £5mln
It’s hived off its skin division, bolstered its board and has already won new business contracts worth €5.7mln so far this year
OptiBiotix is seeking an AIM listing for its SkinBioTherapeutics subsidiary
Wanda has offloaded its holding in digital health platform OncoVerse to BTG plc for an undisclosed sum
The two will work together to develop and initiate a liver cancer program testing Clevegen in clinical trials
Bristol is licensing an experimental neurodegenerative disorder drug to Biogen and a Duchenne muscular dystrophy treatment to Roche
Enrico Vanni has bought another 100,000 shares at 27.5p a pop
The Rookie Investors has still got the Fever(tree), but would he have done had he set a stop-loss?
As I venture into the world of equity trading, here’s the background to my story and where I’m at now
UK housebuilders were in favour with the brokers after a survey showed sentiment is strong in the housing industry
Exane BNP Paribas and Bernstein both upped their recommendations for the supermarket chain